Enhanced Responses to Angiogenic Cues Underlie the Pathogenesis of Hereditary Hemorrhagic Telangiectasia 2

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Choi, Eun Jung ^a   Kim, Yong Hwan ^a   Choe, Se Woon ^a   Tak, Yu Gyoung ^b   Garrido Martin, Eva M ^a   Chang, Myron ^c   Lee, Young Jae ^a,b   Oh, S Paul ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Gachon University   (South Korea)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN 9; SMAD1 PROTEIN; SMAD5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RENDU OSLER WEBER DISEASE;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; CELL LINE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GENE KNOCKOUT TECHNIQUES; GENE ORDER; GENE TARGETING; GENOTYPE; GROWTH DIFFERENTIATION FACTOR 2; HUMANS; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; SMAD PROTEINS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 84877635803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063138     Document Type: Article

References (61)

1. Kjeldsen AD, Vase P, Green A, (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245: 31-39.
2. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, et al. (2002) Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19: 140-148.
3. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, et al. (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91: 66-67.
4. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, et al. (1994) Endoglin, A Tgf-Beta Binding-Protein of Endothelial-Cells, Is the Gene for Hereditary Hemorrhagic Telangiectasia Type-1. Nat Genet 8: 345-351.
5. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, et al. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13: 189-195.
6. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, et al. (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363: 852-859.
7. Cole SG, Begbie ME, Wallace GM, Shovlin CL, (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42: 577-582.
8. Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, et al. (2006) A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 140: 2155-2162.
9. Chang H, Lau AL, Matzuk MM, (2001) Studying TGF-beta superfamily signaling by knockouts and knockins. Mol Cell Endocrinol 180: 39-46.
10. Piek E, Heldin CH, ten Dijke P, (1999) Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13: 2105-2124.
11. Massague J, (1998) TGF-beta signal transduction. Ann Rev Biochem 67: 753-791.
12. Derynck R, Zhang YE, (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
13. Zhang YE, (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19: 128-139.
14. Guo X, Wang XF, (2009) Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19: 71-88.
15. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, et al. (1994) Characterization of type I receptors for transforming growth factor-beta and activin. Science 264: 101-104.
16. Lux A, Attisano L, Marchuk DA, (1999) Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 274: 9984-9992.
17. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S, (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109: 1953-1961.
18. Chen YG, Massague J, (1999) Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J Biol Chem 274: 3672-3677.
19. David L, Mallet C, Keramidas M, Lamande N, Gasc JM, et al. (2008) Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor. Circ Res 102: 914-922.
20. Seki T, Yun J, Oh SP, (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93: 682-689.
21. Park SO, Lee YJ, Seki T, Hong KH, Fliess N, et al. (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 (HHT2). Blood 111: 633-642.
22. Park SO, Wankhede M, Lee YJ, Choi EJ, Fliess N, et al. (2009) Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119: 3487-3496.
23. Lamouille S, Mallet C, Feige JJ, Bailly S, (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100: 4495-4501.
24. Mallet C, Vittet D, Feige JJ, Bailly S, (2006) TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 24: 2420-2427.
25. David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, et al. (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213: 484-489.
26. Korchynskyi O, ten Dijke P, (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277: 4883-4891.
27. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21: 1743-1753.
28. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12: 817-828.
29. Goumans MJ, Lebrin F, Valdimarsdottir G, (2003) Controlling the angiogenic switch: a balance between two distinct TGF-β receptor signaling pathways. Trends Cardiovasc Med 13: 301-307.
30. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, et al. (2004) Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 23: 4018-4028.
31. van Meeteren LA, Thorikay M, Bergqvist S, Pardali E, Stampino CG, et al. (2012) Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting. J Bioll Chem 287: 18551-18561.
32. Mitchell D, Pobre EG, Mulivor AW, Grinberg AV, Castonguay R, et al. (2010) ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth. Mol Cancer Ther 9: 379-388.
33. Cunha SI, Pardali E, Thorikay M, Anderberg C, Hawinkels L, et al. (2010) Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med 207: 85-100.
34. Roman BL, Pham VN, Lawson ND, Kulik M, Childs S, et al. (2002) Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129: 3009-3019.
35. Corti P, Young S, Chen CY, Patrick MJ, Rochon ER, et al. (2011) Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development 138: 1573-1582.
36. Suzuki Y, Ohga N, Morishita Y, Hida K, Miyazono K, et al. (2010) BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. J Cell Sci 123: 1684-1692.
37. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, et al. (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120: 964-972.
38. Lednicky JA, Butel JS, (1997) Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol 78 (Pt 7): 1697-1705.
39. Stewart AR, Lednicky JA, Butel JS, (1998) Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J Neurovirol 4: 182-193.
40. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97: 2626-2631.
41. Hong KH, Lee YJ, Lee E, Park SO, Han C, et al. (2008) Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 118: 722-730.
42. Seki T, Hong KH, Yun J, Kim SJ, Oh SP, (2004) Isolation of a regulatory region of activin receptor-like kinase 1 gene sufficient for arterial endothelium-specific expression. Circ Res 94: e72-e77.
43. Staton CA, Stribbling SM, Tazzyman S, Hughes R, Brown NJ, et al. (2004) Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85: 233-248.
44. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, et al. (1992) Methods in Laboratory Investigation- A Simple, Quantitative Method for Assessing Angiogenesis and Antiangiogenic Agents Using Reconstituted Basement-Membrane, Heparin, and Fibroblast Growth-Factor. Lab Invest 67: 519-528.
45. Brown MA, Zhao Q, Baker KA, Naik C, Chen C, et al. (2005) Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280: 25111-25118.
46. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, et al. (2008) BMP type I receptor inhibition reduces heterotopic ossification. Nat Med 14: 1363-1369.
47. Vogt J, Traynor R, Sapkota GP, (2011) The specificities of small molecule inhibitors of the TGF beta and BMP pathways. Cell Signal 23: 1831-1842.
48. Abdalla SA, Pece-Barbara N, Vera S, Tapia E, Paez E, et al. (2000) Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 9: 1227-1237.
49. Pece-Barbara N, Cymerman U, Vera S, Marchuk DA, Letarte M, (2009) Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet 8: 2171-2181.
50. Hao Q, Zhu YQ, Shen FX, Yang GY, Su H, et al. (2010) Cerebrovascular Dysplasia in Endoglin and Alk1 Haploinsufficient Mice After VEGF Stimulation: Evidence for a "Response-to-Injury" Hypothesis for Hereditary Hemorrhagic Telangectasia. Stroke 41: E264.
51. Walker EJ, Su H, Shen FX, Choi EJ, Oh SP, et al. (2011) Arteriovenous Malformation in the Adult Mouse Brain Resembling the Human Disease. Ann Neurol 69: 954-962.
52. Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, et al. (2000) Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156: 911-923.
53. Shao ES, Lin L, Yao Y, Bostrom KI, (2009) Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood 114: 2197-2206.
54. Kim JH, Peacock MR, George SC, Hughes CCW, (2009) BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. Angiogenesis 15: 497-509.
55. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, et al. (2004) Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 23: 4018-4028.
56. David L, Feige JJ, Bailly S, (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20: 203-212.
57. Larrivee B, Prahst C, Gordon E, del Toro R, Mathivet T, et al. (2012) ALK1 Signaling Inhibits Angiogenesis by Cooperating with the Notch Pathway. Dev Cell 22: 489-500.
58. Ricard N, Ciais D, Levet S, Subileau M, Mallet C, et al. (2012) BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 119: 6162-6171.
59. Mahmoud M, Allinson KR, Zhai ZH, Oakenfull R, Ghandi P, et al. (2010) Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin. Circ Res 106: 1425-U270.
60. Lee NY, Golzio C, Gatza CE, Sharma A, Katsanis N, et al. (2012) Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis. Mol Biol Cell 23: 2412-2423.
61. Ray BN, Lee NY, How T, Blobe GC, (2010) ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis 31: 435-441.